Merck & Co., Inc. (NYSE:MRK) is one of the most undervalued blue chip stocks to buy according to hedge funds. On July 21, ...

Oppenheimer Asset Management on Monday raised its year-end target for the S&P 500 index to 7,100, the highest among major ...

Detailed price information for Integer Holdings Corp (ITGR-N) from The Globe and Mail including charting and trades.

Oppenheimer analyst Brian Nagel sees upside in Carvana stock to $450. CVNA is set to report its fiscal second-quarter ...

Analysts upgraded Carvana shares, arguing the company is a "digitally-driven disruptor" in the fractured used car market.

In a recent market update, Boston Scientific’s financial trajectory got a new spin with Oppenheimer raising its price target ...

Fintel reports that on July 21, 2025, Oppenheimer initiated coverage of Affirm Holdings (NasdaqGS:AFRM) with a Outperform ...

Affirm presents investors an opportunity to “buy now, gain later,” say Oppenheimer analysts who set an $80 price target.

Christopher Nolan’s The Odyssey is already causing a frenzy. The Imax 70MM release starring Matt Damon just pulled off ...

Oppenheimer & Co. Inc. (Oppenheimer), a principal subsidiary of Oppenheimer Holdings Inc. (OPY on the New York Stock Exchange), and its affiliates provide a full range of wealth management ...